Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.
) on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.
At day 11, around 76% of the patients in the 5-day treatment group showed improvement in clinical status versus 66% for standard care alone, Gilead said. Remdesivir is being closely watched after the U.S. Food and Drug Administration granted emergency use authorization last month, citing results from a U.S. government study that showed the drug reduced hospitalization stays by 31%, or about four days, compared to a placebo.
The drug has received approval by Japanese health regulators. U.S. approval requires a rigorous, time consuming FDA review, but EUAs can be used in a health crisis when other options are not available.The drug, which previously failed as a treatment for Ebola, is designed to disable the mechanism by which certain viruses, including the new coronavirus, make copies of themselves and potentially overwhelm their host’s immune system.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Gilead trades that made millions on COVID-19 drug news raise eyebrowsWell-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug treatment may draw regulatory scrutiny, experts said.
続きを読む »
Gilead says remdesivir helped moderate COVID-19 patients improveGilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study.
続きを読む »
Canada to promote holidays at home because of COVID-19 border closuresCanada will invest C$30 million ($21.8 million) to enable its provinces and territories to promote holidays in their 'own back yard' because of the closure of the country's borders due to the novel coronavirus pandemic.
続きを読む »
As America passes a grim milestone, how is it handling covid-19?“Almost a third of people in their prime working years don’t have jobs. The last time that was true was the 1970s.” Henry_Curr looks at the economic impact of the pandemic on our “Checks and Balance” podcast
続きを読む »
Hundreds of South Korean schools closed amid spike in COVID-19 cases - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
Roberts Upholds COVID-19 Restrictions on Churches, Scolds KavanaughThe chief justice has lost patience with conservatives' efforts to overturn public health orders.
続きを読む »